- Early experiences with PD-1 inhibitor treatment of platinum resistant epithelial ovarian cancer
-
Normann MC, Türzer M, Diep LM, Oldenburg , Gajdzik B, Solheim O, Rud E
- KMID: 2450235
- J Gynecol Oncol.
- 2019 Jul;30(4):e56.
- doi: 10.3802/jgo.2019.30.e56
OBJECTIVE: In this study, we evaluated the toxicity and clinical efficacy of nivolumab, a programmed cell death protein 1 (PD-1) inhibitor, on patients with platinum resistant ovarian cancer. METHODS: Every second... -
- CITED
-
- Close
- SHARE
-
- Close
